Regeneron Pharmaceuticals (REGN) News Today → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free REGN Stock Alerts $883.20 -7.48 (-0.84%) (As of 04/26/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRussell Investments Group Ltd. Has $106.32 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 28 at 12:26 PMRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by PGGM Investmentsmarketbeat.com - April 27 at 5:38 PMAnalysts Are Bullish on Top Healthcare Stocks: Regeneron (REGN), Gilead Sciences (GILD)markets.businessinsider.com - April 26 at 12:58 PMRegeneron Pharmaceuticals (NASDAQ:REGN) PT Raised to $1,030.00 at TD Cowenamericanbankingnews.com - April 26 at 4:46 AMPrentiss Smith & Co. Inc. Trims Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 25 at 8:52 PMWells Fargo Reaffirms Their Buy Rating on Regeneron (REGN)markets.businessinsider.com - April 25 at 10:12 AMRegeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseasesmarkets.businessinsider.com - April 25 at 10:12 AMRegeneron, Mammoth in pact to develop CRISPR-based gene editing therapiesmsn.com - April 25 at 10:12 AMJennifer Doudna co-founded Peninsula biotech lands CRISPR gene-editing pact with Regeneronbizjournals.com - April 25 at 10:12 AMUPDATE 1-AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in studyfinance.yahoo.com - April 25 at 10:12 AMAbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in studyreuters.com - April 25 at 8:48 AMRegeneron to collaborate on gene editing therapies with Doudna-founded Mammothreuters.com - April 25 at 7:14 AMRegeneron Pharmaceuticals (REGN) Scheduled to Post Earnings on Thursdayamericanbankingnews.com - April 25 at 1:28 AMRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alaska Permanent Fund Corpmarketbeat.com - April 24 at 5:16 PMRegeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $1,030.00 at TD Cowenmarketbeat.com - April 24 at 1:57 PMRegeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCOglobenewswire.com - April 24 at 10:05 AMCantor Fitzgerald Brokers Raise Earnings Estimates for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)americanbankingnews.com - April 24 at 2:24 AMNew York State Common Retirement Fund Has $131.92 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 23 at 12:28 PMFY2024 EPS Estimates for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Raised by Analystmarketbeat.com - April 23 at 6:14 AMLoring Wolcott & Coolidge Fiduciary Advisors LLP MA Buys 17,529 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 22 at 11:39 PMRegeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)globenewswire.com - April 22 at 5:54 PMShikiar Asset Management Inc. Cuts Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 21 at 5:00 PMRegeneron Pharmaceuticals (NASDAQ:REGN) Shares Gap Up to $893.99americanbankingnews.com - April 21 at 1:42 AMabrdn plc Buys 186,215 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 20 at 12:10 PMRegeneron Pharmaceuticals (NASDAQ:REGN) Lowered to Buy at StockNews.comamericanbankingnews.com - April 20 at 2:18 AMRegeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Cautionfinance.yahoo.com - April 19 at 12:59 PMRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Holdings Lifted by Xponance Inc.marketbeat.com - April 19 at 10:17 AMUBS Group Increases Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $1,099.00americanbankingnews.com - April 19 at 2:36 AMThe Law Offices of Frank R. Cruz Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investorsbusinesswire.com - April 17 at 2:15 PMCantor Fitzgerald Reaffirms Their Hold Rating on Regeneron (REGN)markets.businessinsider.com - April 17 at 1:28 PMIf You Invested $100 In This Stock 20 Years Ago, You Would Have $6,700 Todaybenzinga.com - April 17 at 1:28 PMVontobel Holding Ltd. Has $6.24 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 17 at 6:18 AMRegeneron to “vigorously defend” against DOJ on Eylea pricing complaintmsn.com - April 16 at 8:37 PMHealthInvest Partners AB Invests $3.50 Million in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 16 at 6:50 PMRegeneron to defend against DOJ complaint on drug-price manipulationfinance.yahoo.com - April 15 at 11:56 PMUPDATE 1-Regeneron to defend against DOJ complaint on drug-price manipulationfinance.yahoo.com - April 15 at 11:56 PMRegeneron to defend US Justice Department's complaint on drug-pricing manipulationreuters.com - April 15 at 7:24 PMCantor Fitzgerald Reaffirms "Neutral" Rating for Regeneron Pharmaceuticals (NASDAQ:REGN)marketbeat.com - April 15 at 3:31 PMSumitomo Mitsui Trust Holdings Inc. Has $280.48 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 15 at 8:44 AMMn Services Vermogensbeheer B.V. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 13 at 7:31 PMRegeneron Pharmaceuticals (NASDAQ:REGN) Lifted to Strong-Buy at StockNews.commarketbeat.com - April 12 at 11:17 PMNewEdge Wealth LLC Raises Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 12 at 9:03 PMAnalysts Are Bullish on These Healthcare Stocks: BioMarin Pharmaceutical (BMRN), Regeneron (REGN)markets.businessinsider.com - April 12 at 12:47 PMBreaking Down Regeneron Pharmaceuticals: 13 Analysts Share Their Viewsmarkets.businessinsider.com - April 12 at 12:47 PMBank of America Raises Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $720.00marketbeat.com - April 12 at 8:27 AMEye Drug Eylea Price Manipulation: Regeneron Faces US Justice Department Allegations Over Medicare Pricing Of Its Best-Selling Eye Drugmsn.com - April 11 at 3:54 PMAre Regeneron's Legal Troubles — And Six-Week Slide — A Buying Opportunity?investors.com - April 11 at 1:01 PMRegeneron Pharmaceuticals (NASDAQ:REGN) Shares Down 2.6% marketbeat.com - April 11 at 12:45 PMUS accuses Regeneron of fraudulent price reporting for eye drugmsn.com - April 11 at 10:32 AMThese Stocks Are Moving the Most Today: CarMax, Fastenal, Alpine Immune, Nike, Robinhood, Constellation Brands, and Morefinance.yahoo.com - April 11 at 10:32 AM Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address His win rate puts Warren Buffett to shame… (Ad)Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss. Click here now for the full story. REGN Media Mentions By Week REGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REGN News Sentiment▼0.680.33▲Average Medical News Sentiment REGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REGN Articles This Week▼2514▲REGN Articles Average Week Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Vertex Pharmaceuticals News Bristol-Myers Squibb News GSK News Sanofi News Zoetis News Pfizer News Takeda Pharmaceutical News Royalty Pharma News BeiGene News Catalent News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:REGN) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressGreat Crypto BullWeiss RatingsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
